Cancer Research And Biostatistics (CRAB)
Damien Mar Chong has extensive experience in financial leadership roles. From 2023, they have been serving as the Board Treasurer at IFTAS. Prior to that, they worked at Cancer Research And Biostatistics (CRAB) as the Vice President - Treasurer and Chief Financial Officer, where they were responsible for the fiscal direction of the organization and provided leadership in various departments. Before their role at CRAB, Damien had a self-employed sabbatical from 2019 to 2022. Damien also worked at Lumetra Healthcare Solutions as the Chief Financial Officer & Vice President, Operations, where they partnered with executive management and oversaw financial statement preparation, planning, and analysis. Damien has also held positions such as Chief Financial Officer at BALANCE/Consumer Credit Counseling Service of San Francisco and Vice President at Lumetra Healthcare Solutions. Damien began their career at Stanford University as a Senior Financial Analyst, and earlier at Optimized Systems & Solutions as a Senior Financial Analyst.
Damien Mar Chong completed their high school education at Presentation College from 1987 to 1994. Damien then pursued a Bachelor of Business Administration degree, with a major in Finance and International Business and a minor in Economics, at the University of Hawaii - Shidler College of Business from 1994 to 1998. Later, they attended the University of California, Davis - Graduate School of Management from 2006 to 2009, where they obtained their Master of Business Administration degree with a specialization in Finance.
This person is not in any teams
Cancer Research And Biostatistics (CRAB)
1 followers
Cancer Research And Biostatistics (CRAB)® is a non-profit organization whose mission is to help conquer cancer, and other diseases. Since 1997, CRAB has supported over 300 clinical trials in partnership with foundations, universities, pharmaceutical and biotech companies. Past project experience has ranged from phase I to phase III, registration, staging, and prevention trials. CRAB provides a constellation of services that can help with concept creation, trial conduct, and regulatory submission or publication. Dr. Antje Hoering serves as President and CEO. Dr. John Crowley, co-founder with Dr. Cay Crowley, is Chairman of the Board of Directors. CRAB believes that collaboration accelerates outcomes. CRAB has long-standing partnerships with several cancer research organizations, including the SWOG Cancer Research Network, The Hope Foundation for Cancer Research, and SWOG Clinical Trials Partnerships. SWOG is one of five National Cancer Institute (NCI) supported members of the National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). CRAB and Fred Hutchinson Cancer Research Center make up the SWOG Statistics and Data Management Center (SDMC). CRAB is also an integral collaborator with the International Association for the Study of Lung Cancer (IASLC) since the late 1990s, publishing analysis for over 200,000 lung cancer cases in the 7th and 8th editions of the Staging Manuals. CRAB currently serves as the Independent Analysis Center for Friends of Cancer Research’s ctDNA for Monitoring Treatment Response (ctMoniTR) Project. In this project, CRAB receives data from the pharmaceutical and diagnostic partners, coordinates input from collaborators, harmonizes and pools data, and analyzes the pooled data to meet the project’s objectives. Message us to learn how we can support you in your next clinical trial, or partner with you, to continue to make strides in preventing and curing cancer.